After a three-decade drought of new antibiotics to treat gonorrhea, the FDA has signed off on two first-in-class oral ...
How structural and data-driven innovation are converging to address the liquidity challenge in private markets ...
Phase 3 findings show oral zoliflodacin to be non-inferior to the combination of ceftriaxone and azithromycin for the ...
In other City news, the City of Freeport has ceremoniously passed a resolution to become Sister Cities with Lititz, ...
Allied Market Research published a report, titled, "Immunostimulant Market by Product Type (Vaccines, Colony Stimulating ...
Allied Market Research published a report, titled, " Cardiovascular Diagnostic Device Market by Type (Electrocardiogram ...
Plans to build 13 affordable housing units in a vacant and fire-damaged building at the Leopards Club International (Bermuda) ...
Global trade is on course to exceed $35 trillion in 2025 for the first time, according to UNCTAD’s final Global Trade Update of the year. The new data confirm that trade continued expanding through ...
A collective sigh of relief reverberated from Monmouth County to Trenton to Hollywood Dec. 5 when Netflix and the Fort ...
The Council has agreed on an amendment to the regulation that sets the framework for the activities of the European ...
Allschwil, Switzerland, December 11, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company ...
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE® (zoliflodacin) for oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback